International Journal of Health and Clinical Research

Yazarlar: Madhu Balla, Vijay Kumar, Manpreet Kour

Konular:-

Anahtar Kelimeler:Anemia,Chronic Kidney Disease.

Özet: Background: Chronic kidney disease (CKD) has emerged as a public health challenge in countries around the world. Anemia is a well-known complication in chronic kidney disease (CKD) and associated with progression of CKD, poor quality of life, and increase in morbidity and mortality.Early identification and treatment of anemia may improve CVS morbidity and mortality however, its identification and management have been reported to be suboptimal. Aim of study: This study aimed to determine the prevalence of anemia in chronic kidney disease patients in a tertiary care hospital. Methods: A cross sectional and observational study was conducted in a tertiary care hospital during the study period of August 2017 to February 2018. Results: A total of 121 participants were included to estimate the prevalence of anemia among chronic kidney disease patients. Most of the patients ( 47.10% ) belonged to the middle age group 40 to 60 years. Female patients (58.67%) were suffering from more CKD than the male patients (41.32%). Most of the patients (61.15%) were anemic. 46.28% CKD patients also suffering from diabetes mellitus. Most of the patients (54.54%) treated with oral iron agents for anemia in CKD patients. Conclusion: In this study most of the chronic kidney disease patients were anemic. Each center should determine the treatment strategy according to the patient’s characteristics. Periodic screening and intervention programs for anemia of CKD should be practiced to change the existing situation in the setting.

---